Navigation Links
Cantel Medical Acquires the Sterilization Monitoring Business of ConFirm Monitoring Systems, Inc.
Date:2/14/2011

LITTLE FALLS, N.J., Feb. 14, 2011 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMN), through its Crosstex International subsidiary, has further expanded its infection prevention and control business by purchasing the sterilization monitoring business of ConFirm Monitoring Systems, Inc.  Based in Denver, Colorado, ConFirm is one of the leading providers of biological monitoring services in North America.  

ConFirm offers both a mail-in service and in-office spore test kits for healthcare professionals to verify the performance of their sterilizers in accordance with industry guidelines for daily or weekly testing.  With approximately $4.0 million in GAAP sales, the privately-held enterprise was founded 10 years ago and conducts over two million tests per year.  The purchase price is comprised of $7.5 million in cash at closing and contingent consideration of up to an additional $1.0 million based on achievement of specified sales levels through January 31, 2012.  The transaction is expected to be slightly accretive to Cantel's earnings per share in the first full fiscal year.

According to Gary Steinberg, CEO of Crosstex, "ConFirm is an ideal addition to our sterilization product portfolio.  Given that the sterilizer is a critical component of infection control in every dental office and most healthcare facilities, we want to provide the most effective tools to ensure it is functioning properly.  When used in conjunction with our patent-pending Sure-Check® sterilization pouch, ConFirm's biological monitoring systems enable us to provide the highest form of sterility assurance."

Andrew Krakauer, CEO of Cantel Medical added, "I am very impressed with the employees, operations, and high service-orientation of ConFirm. We are delighted that Mark Frampton will continue as the general manager for at least the first year.  Crosstex will be retaining the Denver operation and all of the aligned employees to ensure a smooth transition for all distributors and end-users.  I see this as a great opportunity to leverage the strong sales and marketing capabilities of our Crosstex platform."

About Crosstex International

A subsidiary of Cantel Medical Corp., Crosstex, founded in 1953, has its headquarters and major manufacturing operations in Hauppauge, New York. Sold throughout the world, Crosstex branded and private label products include sterilization pouches and accessories, face masks, patient towels and bibs, disinfectants, germicidal wipes, hand care products, gloves, eyewear, sponges, cotton products, scalpels and blades, sharps containers, saliva ejectors and evacuation tips.  For further information, visit the Crosstex website at http://www.crosstex.com.

About Cantel Medical Corp.

Cantel Medical Corp. (NYSE: CMN) is a leading provider of infection prevention and control products in the healthcare market. Our products include water purification equipment, sterilants, disinfectants and cleaners, specialized medical device reprocessing systems for endoscopy and renal dialysis, disposable infection control products primarily for the dental industry, dialysate concentrates and other dialysis supplies, hollow fiber membrane filtration and separation products for medical and non-medical applications, and specialty packaging for infectious and biological specimens. We also provide technical maintenance for our products and offer compliance training services for the transport of infectious and biological specimens.  For further information, visit the Cantel website at http://www.cantelmedical.com.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including, without limitation, the risks detailed in Cantel's filings and reports with the Securities and Exchange Commission. Such forward-looking statements are only predictions, and actual events or results may differ materially from those projected or anticipated.


'/>"/>
SOURCE Cantel Medical Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Cantel Medical Corp. To Hold Conference call to Discuss Fourth Quarter and Fiscal 2008 Results
2. Larta Institute NIH Success Stories Featured in 2011 California Biomedical Industry Report
3. DiaTech Oncology and Walter Reed Army Medical Center Establish Pilot to Determine Best Chemotherapy for Cancer Patients
4. Gizmox Enters the Business Mobile Application Market - Visual WebGui Based Solutions Deployed in Major Financial and Medical Institutions
5. Californias Biomedical Industry is Poised for Growth Despite Increasing Global Competition, According to the 2011 California Biomedical Industry Report
6. Ingenuity Systems and Erasmus University Medical Center Collaborate on Next-Generation Sequencing Project to Accelerate Disease Research
7. Professor Dennis Lo Trisomy 21 Clinical Validation Study Published in British Medical Journal
8. Boston Scientific Acquires Intelect Medical
9. HRC Medical Center Offers Patients Relief with Innovative Bio-Identical Hormone Replacement Therapy
10. NOVAVAX and University of Massachusetts Medical School Publish Preclinical Safety and Efficacy Study of a Respiratory Syncytial Virus (RSV) Virus-like Particle (VLP) Vaccine Candidate
11. Aethlon Medical Announces Washington, DC Shareholder Presentation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Brooklyn, NY (PRWEB) , ... June 24, 2016 , ... ... 15mm, machines such as the Cary 5000 and the 6000i models are higher end ... height is the height of the spectrophotometer’s light beam from the bottom of the ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... pleased to announce the launch of their brand, UP4™ Probiotics, into Target stores ... 35 years, is proud to add Target to its list of well-respected retailers. ...
(Date:6/23/2016)... A person commits a crime, and the detective ... the criminal down. An outbreak of foodborne illness ... (FDA) uses DNA evidence to track down the bacteria that ... It,s not. The FDA has increasingly used a complex, cutting-edge ... illnesses. Put as simply as possible, whole genome sequencing is ...
(Date:6/23/2016)... MONICA, Calif. , June 23, 2016  The Prostate Cancer Foundation ... pioneer increasingly precise treatments and faster cures for prostate cancer. Members of the ... institutions across 15 countries. Read More About the Class ... ... ...
Breaking Biology Technology:
(Date:4/26/2016)... , April 27, 2016 ... the  "Global Multi-modal Biometrics Market 2016-2020"  report to ... ) , The analysts forecast the ... CAGR of 15.49% during the period 2016-2020.  ... number of sectors such as the healthcare, BFSI, ...
(Date:4/15/2016)... 15, 2016  A new partnership announced today ... underwriting decisions in a fraction of the time ... and high-value life insurance policies to consumers without ... With Force Diagnostics, rapid testing (A1C, Cotinine and ... (blood pressure, weight, pulse, BMI, and activity data) ...
(Date:4/14/2016)... , April 14, 2016 ... and Malware Detection, today announced the appointment of ... the new role. Goldwerger,s leadership appointment comes ... the heels of the deployment of its platform at ... behavioral biometric technology, which discerns unique cognitive and physiological ...
Breaking Biology News(10 mins):